Home

MAPRx Expresses Support for Cost-Smoothing Legislation

Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Senators Bill Cassidy and Bob Menendez in support of their legislation to address out-of-pocket (OOP) costs for Medicare Part D beneficiaries. S. 2911, the Seniors Prescription Drug Relief Act of 2019, includes a much-needed smoothing mechanism that would allow Medicare beneficiaries to spread... Read more

MAPRx Submits Letter Urging Congressional Action on 2020 Out-of-Pocket Cliff

Earlier today, the Medicare Access for Patients Rx (MAPRx) Coalition submitted a letter, signed by 33 member organizations, to Congressional leadership urging them to take action to address the looming increase in out-of-pocket (OOP) costs Medicare Part D beneficiaries will incur this year. This increase, known as the "OOP Cliff," is due to the OOP threshold – the amount patients are required... Read more

MAPRx Submits Comment Letter on H.R. 3

Earlier today, the MAPRx Coalition submitted feedback and comments on Title III of H.R. 3, the Lower Drug Costs Now Act of 2019, to the Chairs and Ranking Members of the House of Representatives' Ways & Means, Energy & Commerce, and Education & Labor Committees. The Coalition appreciates the House's leadership in advancing policy to cap out-of-pocket costs for Medicare Part D beneficiaries. The... Read more

MAPRx Releases 2020 Open Enrollment Guide

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2019 – December 7, 2019 for coverage beginning January 1, 2020. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole may also impact how beneficiaries move through the benefit... Read more

MAPRx Submits Letter to Senate Finance Committee on Drug Pricing Legislation

Today, the MAPRx Coalition and 28 of its members, national organizations representing patients, caregivers, and healthcare professionals, submitted a letter to the Senate Finance Committee on their recently released legislation, The 2019 Prescription Drug Pricing Reduction Act of 2019. The Coalition greatly appreciates the Committee's leadership in improving access to prescription drugs for the more than 44 million Americans who rely on Medicare Part... Read more

45 Groups Sign MAPRx Letter to House Committees on Improving Part D

On June 6, MAPRx and 45 national advocacy organizations submitted a letter to leadership in the House of Representatives' Ways and Means Committee and Energy and Commerce Committee with recommendations for improving Medicare Part D. Among other improvements, the letter made clear that the MAPRx Coalition supports a cap on out-of-pocket spending for the more than 44 million Americans who depend on... Read more